{
    "Symbol": "SOLV",
    "AssetType": "Common Stock",
    "Name": "Solventum Corp.",
    "Description": "Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is headquartered in Saint Paul, Minnesota.",
    "CIK": "1964738",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
    "Address": "3M CENTER, BUILDING 275-6W, 2510 CONWAY AVENUE EAST, MAPLEWOOD, MN, UNITED STATES",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "10784012000",
    "EBITDA": "2259000000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "None",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "None",
    "RevenuePerShareTTM": "47.49",
    "ProfitMargin": "0.157",
    "OperatingMarginTTM": "0.189",
    "ReturnOnAssetsTTM": "0.0766",
    "ReturnOnEquityTTM": "0.166",
    "RevenueTTM": "8202000000",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "0",
    "QuarterlyEarningsGrowthYOY": "-0.193",
    "QuarterlyRevenueGrowthYOY": "0.002",
    "AnalystTargetPrice": "69.67",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "3",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.315",
    "PriceToBookRatio": "2.92",
    "EVToRevenue": "2.25",
    "EVToEBITDA": "9.09",
    "Beta": "None",
    "52WeekHigh": "96.05",
    "52WeekLow": "47.16",
    "50DayMovingAverage": "64.55",
    "200DayMovingAverage": "64.55",
    "SharesOutstanding": "172710000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}